"At OnePharma we are committed to provide access for patients and society to high quality lifesaving therapeutics. We strive to satisfy unmet needs believing that High Quality extends beyond our products to people, services & wherever we step." OnePharma Medics was established in 2009 as a Limited Liability Company (L.L.C.) under the umbrella of Egyptian Law of investment. Since 2009, OnePharma Medics succeeded to provide Egyptian patients with ACCESS to High Quality & Affordable MYLAN Brand Generic products, adding a new hope to more patients coverage with high quality treatments. Throughout years, OnePharma Medics was granted TOP Ranks in the Egyptian Pharmaceutical Market, achieving a highly distinguished position among Multinational & Local pharmaceutical firms. OnePharma Medics as a Market Leader in the field of Oncology, played an extremely effective role leading a massive awareness campaign for the cost effectiveness of shifting from high priced Biological Products to affordable FDA/EMA Approved BIOSIMILARS which in turn has a great impact on Egyptian governmental budget expenditures in favor of Egyptian Health System for: - Treating more patients. - Covering more therapeutic areas. OnePharma Medics believing in Corporate Social Responsibility towards Egyptian Patients Communities, adopted the RARE Diseases topic to raise Awareness for the Patients, HCP and the whole Egyptian Society.